Email Alert RSS
Volume 13 Issue 5
Sep.  2022
Turn off MathJax
Article Contents
Abstract
References
Related Articles
SUN Fangcan, HAN Bing, GAO Yan, SHEN Minhong, CHEN Youguo, ZHONG Wen. Validation of Six Predictive Models for Adverse Outcomes of Hypertensive Disorders of Pregnancy in Eastern and Western China[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 837-844. DOI: 10.12290/xhyxzz.2021-0778
Citation: SUN Fangcan, HAN Bing, GAO Yan, SHEN Minhong, CHEN Youguo, ZHONG Wen. Validation of Six Predictive Models for Adverse Outcomes of Hypertensive Disorders of Pregnancy in Eastern and Western China[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 837-844. DOI: 10.12290/xhyxzz.2021-0778
shu

Validation of Six Predictive Models for Adverse Outcomes of Hypertensive Disorders of Pregnancy in Eastern and Western China

  • 1.

    The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China

  • 2.

    Department of Obstetrics, Sichuan Provincial Maternity and Child Health Care Hospital, Chengdu 610045, China

Funds: 

Jiangsu Commission of Health Research Project H2019010

More Information
  • Corresponding author:

    HAN Bing, E-mail: hanbing@suda.edu.cn

    GAO Yan, E-mail: 290475126@qq.com

  • Received Date: December 06, 2021
  • Accepted Date: January 24, 2022
  • Issue Publish Date: September 29, 2022
    Graphical Abstract
    • Abstract
  •   Objective  To explore the application value of six prediction models reported at home and abroad for adverse outcomes of hypertensive disorders of pregnancy(HDP) in eastern and western China.
      Methods  For all patients who delivered in the First Affiliated Hospital of Soochow University and Sichuan Provincial Maternal and Child Health Care Hospital from May 1, 2011 to April 30, 2019 and were diagnosed with HDP, their clinical data were retrospectively analyzed. Six models, fullPIERS, miniPIERS, Zwertbroek, PREP, Ngwenya, and Ma Guojun, were used to predict the risk of adverse outcomes for the patients. The predictive performance of the models was evaluated in terms of discrimination and calibration.
      Results  A total of 2978 patients were eligible. Combined adverse outcomes occurred in 13.6% (405/2978) of women within 48 h of admission, and 22.0% (655/2978) at any time during admission. The delivery < 34 weeks (49.4%, 200/405), need for blood product transfusion (43.5%, 176/405), and placental abruption (23.5%, 95/405) were the most common adverse outcomes within 48 hours of admission. The area under of the curve of the six models for predicting adverse outcomes in the patients with HDP within 48 hours of admission/during hospitalization ranged from 0.600 to 0.897, the sensitivity ranged from 57.1% to 69.5%, and the specificity ranged from 60.1% to 76.6%. The Hosmer-Lemeshow test showed that except for the PREP model (which had a small validation population and was not evaluated for calibration), the P-values of all the other 5 models were less than 0.05.
      Conclusions  The six prediction models have certain application value in the prediction of adverse outcomes of HDP patients in the eastern and western regions of China, but the fitting is poor. The predictors involved in some models are not routine inspection indicators, and the feasibility of large-scale model application is still open to question. It is still necessary to establish a better prognostic model suitable for local areas based on Chinese characteristics.
    • FullText(HTML)
    • References (27)
  • [1]
    Agius A, Sultana R, Camenzuli C, et al. An update on the genetics of pre-eclampsia[J]. Minerva Ginecol, 2018, 70: 465-479.
    [2]
    Anon. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia[J]. Obstet Gynecol, 2019, 133: 1.
    [3]
    孙芳璨, 韩冰. 妊娠期高血压疾病不良结局预测模型的研究进展[J]. 实用妇产科杂志, 2019, 35: 677-681. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201909013.htm

    Sun FC, Han B. Advances in research on predictive models of adverse outcomes of pregnancy-induced hypertension[J]. Shiyong Fuchanke Zazhi, 2019, 35: 677-681. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201909013.htm
    [4]
    Tan J, Qi Y, Liu C, et al. The use of rigorous methods was strongly warranted among prognostic prediction models for obstetric care[J]. J Clin Epidemiol, 2019, 115: 98-105. DOI: 10.1016/j.jclinepi.2019.07.009
    [5]
    中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55: 227-238. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201510002.htm

    Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China(2020)[J]. Zhonghua Fuchanke Zazhi, 2020, 55: 227-238. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201510002.htm
    [6]
    Chan P, Brown M, Simpson JM, et al. Proteinuria in preec-lampsia: how much matters?[J]. Bjog, 2005, 112: 280-285. DOI: 10.1111/j.1471-0528.2004.00395.x
    [7]
    Millman AL, Payne B, Qu Z, et al. Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia[J]. J Obstet Gynaecol Can, 2011, 33: 705-714. DOI: 10.1016/S1701-2163(16)34955-6
    [8]
    von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model[J]. Lancet, 2011, 377: 219-227. DOI: 10.1016/S0140-6736(10)61351-7
    [9]
    Payne BA, Hutcheon JA, Ansermino JM, et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS(Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study[J]. PLoS Med, 2014, 11: e1001589. DOI: 10.1371/journal.pmed.1001589
    [10]
    Payne BA, Hutcheon JA, Dunsmuir D, et al. Assessing the incremental value of blood oxygen saturation(SpO2) in the miniPIERS(Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model[J]. J Obstet Gynaecol Can, 2015, 37: 16-24. DOI: 10.1016/S1701-2163(15)30358-3
    [11]
    Zwertbroek EF, Broekhuijsen K, Langenveld J, et al. Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy[J]. Acta Obstet Gynecol Scand, 2017, 96: 96-105. DOI: 10.1111/aogs.13051
    [12]
    Thangaratinam S, Allotey J, Marlin N, et al. Prediction of complications in early-onset pre-eclampsia(PREP): development and external multinational validation of prognostic models[J]. BMC Med, 2017, 15: 68. DOI: 10.1186/s12916-017-0827-3
    [13]
    廖媛, 刘兴会, 谭婧, 等. 建立子痫前期不良结局风险预警模型的初步研究[J]. 四川大学学报(医学版), 2018, 49: 797-802. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201805023.htm

    Liao Y, Liu XH, Tan J, et al. Development of a predictive model for adverse outcomes of preeclampsia[J]. Sichuan Daxue Xuebao(Yixueban), 2018, 49: 797-802. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201805023.htm
    [14]
    Chen R, Han Q, Zheng L, et al. Establishment and assessment of a nomogram for predicting adverse outcomes of preterm preeclampsia[J]. J Int Med Res, 2020, 48: 300060520911828.
    [15]
    Ngwenya S, Jones B, Mwembe D, et al. Development and validation of risk prediction models for adverse maternal and neonatal outcomes in severe preeclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe[J]. Pregnancy Hypertens, 2020, 23: 18-26.
    [16]
    Tan J, Yang M, Liao Y, et al. Development and validation of a prediction model on severe maternal outcomes among pregnant women with pre-eclampsia: a 10-year cohort study[J]. Sci Rep, 2020, 10: 15590. DOI: 10.1038/s41598-020-72527-0
    [17]
    马国珺, 庄旭, 邓东锐, 等. 重度子痫前期患者脏器损伤与不良妊娠结局相关性的多中心研究[J]. 实用妇产科杂志, 2020, 36: 443-447. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ202006016.htm

    Ma GJ, Zhuang X, Deng DR, et al. The Correlation between Organ Function Impairment and Adverse Pregnancy Outcome in Patients with Severe Preeclampsia: a Multicenter Study[J]. Shiyong Fuchanke Zazhi, 2020, 36: 443-447. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ202006016.htm
    [18]
    Ukah UV, Payne BA, Hutcheon JA, et al. Placental growth factor for the prognosis of women with preeclampsia(fullPIERS model extension): context matters[J]. BMC Pregnancy Childbirth, 2020, 20: 668. DOI: 10.1186/s12884-020-03332-w
    [19]
    Saleh L, Alblas MM, Nieboer D, et al. Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model[J]. Ultrasound Obstet Gynecol, 2021, 58: 698-704. DOI: 10.1002/uog.23142
    [20]
    沈敏红, 韩冰. fullPIERS预测模型用于574例妊娠高血压人群的初探[J]. 现代妇产科进展, 2012, 21: 172-174, 178. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201203004.htm

    Shen MH, Han B. A preliminary study by using fulIPIERS model in adverse outcome prediction in 574 patients of pregnancy induced hypertension in China[J]. Xiandai Fuchanke Jinzhan, 2012, 21: 172-174, 178. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201203004.htm
    [21]
    Heestermans T, Payne B, Kayode GA, et al. Prognostic models for adverse pregnancy outcomes in low-income and middle-income countries: a systematic review[J]. BMJ Glob Health, 2019, 4: e001759. DOI: 10.1136/bmjgh-2019-001759
    [22]
    Daru J, Zamora J, Fernández-Félix BM, et al. Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: a multilevel analysis[J]. Lancet Glob Health, 2018, 6: e548-e554.
    [23]
    Chappell LC, Brocklehurst P, Green ME, et al. Planned early delivery or expectant management for late preterm pre-eclampsia(PHOENIX): a randomised controlled trial[J]. Lancet, 2019, 394: 1181-1190.
    [24]
    Sinkey RG, Battarbee AN, Bello NA, et al. Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines[J]. Curr Hypertens Rep, 2020, 22: 66.
    [25]
    Scott G, Gillon TE, Pels A, et al. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension[J]. Am J Obstet Gynecol, 2022, 226: S1222-S1236.
    [26]
    Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction[J]. Am J Obstet Gynecol, 2022, 226: S1071-S1097. e2.
    [27]
    Lim S, Li W, Kemper J, et al. Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia: A Systematic Review and Meta-analysis[J]. Obstet Gynecol, 2021, 137: 72-81.
    • Related Articles

  • Related Articles

    [1]SUN Wenjuan, ZHANG Bo. Current Situation and Implications of Novel Antitumer Drugs in China[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1036-1044. DOI: 10.12290/xhyxzz.2021-0521
    [2]CHEN Chen, HAN Xiaohong. Clinical Trials of Rare Diseases in China over One Decade: Based on the Chinese First List of Rare Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1028-1035. DOI: 10.12290/xhyxzz.2022-0010
    [3]HE Shan, GAO Shiqi, HE Xinyue, LIU Peng, JIN Ye, LI Xiangyan, ZHU Yicheng, CHEN Limeng, ZHU Weiguo, ZHANG Shuyang. Advances in Rare Diseases in China (2020—2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(1): 39-45. DOI: 10.12290/xhyxzz.2021-0248
    [4]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅴ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 658-665. DOI: 10.12290/xhyxzz.20210005
    [5]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅳ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 650-657. DOI: 10.12290/xhyxzz.20210004
    [6]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅲ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 641-649. DOI: 10.12290/xhyxzz.20210003
    [7]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China (2021)(Ⅱ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 632-640. DOI: 10.12290/xhyxzz.20210002
    [8]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China (2021)(Ⅰ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 624-631. DOI: 10.12290/xhyxzz.20210001
    [9]Jing FAN, Xu-dong MA, Yan-hong GUO. Striking Improvements in the Technological Capability and the Quality of Healthcare in China[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(4): 303-306. DOI: 10.3969/j.issn.1674-9081.2018.04.004
    [10]Hao-peng XU, Chong ZHU, Meng-chun GONG, Shu-yang ZHANG. Research of Rare Diseases in China: from the Past to the Future[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(1): 5-9. DOI: 10.3969/j.issn.1674-9081.2018.01.002

  • Cited by

    Periodical cited type(7)

    1. 杨利伟. 同意原则的伦理向度:从生命伦理到多元实践. 道德与文明. 2025(01): 145-156 .
    2. 夏振兰，刘俊荣，刘泽炫，陈丽萍. 慢性伤口处理中的临床伦理困境探析——以1例产后脂肪液化合并线结反应的慢性伤口患者护理为例. 中国医学伦理学. 2024(02): 194-198 .
    3. 朱敏，陈昌林，李明. 老年患者麻醉知情同意的临床伦理分析. 中国当代医药. 2024(14): 124-128 .
    4. 王茜，夏曼. 知情同意权的伦理应用困境与对策. 江苏卫生事业管理. 2024(11): 1559-1562 .
    5. 陶应时，陈巧，刘红玉. 治疗型脑机接口的知情同意问题及其应对. 南华大学学报(社会科学版). 2023(01): 62-68 .
    6. 夏振兰，陈丽萍，杨林玲，廖绮霞，刘俊荣. 一例慢性伤口不愈合患者拒绝住院治疗的伦理剖析. 中国医学伦理学. 2022(09): 1012-1016 .
    7. 张曼. 脑隐私法律概念建构：路径、特性与贡献. 东方法学. 2022(05): 60-73 .

    Other cited types(4)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (647) PDF downloads (37) Cited by(11)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close